Skip to search formSkip to main content

Neotigason

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
OBJECTIVE We investigated induction of α-secretase A disintegrin and metalloprotease 10 (ADAM10) by the synthetic retinoid… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
2011
2011
Dear Editor, Erythrokeratodermia variabilis (EKV) is a rare genetic disease which is characterized by the coexistence of… Expand
  • figure 1
  • figure 2
Is this relevant?
2011
2011
A healthy 27-year-old Taiwanese man presented with extensive and recalcitrant plantar warts on his right foot for more than 10… Expand
  • figure 3
  • figure 1
  • figure 2
Is this relevant?
2009
2009
OBJECTIVE Acitretin is used for the treatment of psoriasis. The purpose of this study was to validate an HPLC method for the… Expand
Is this relevant?
Review
2002
Review
2002
Review of preclinical data including genotoxicity assays and a male rat reproduction toxicology study demonstrates that acitretin… Expand
  • table 1
Is this relevant?
1998
1998
Acitretin (Ro 10-1670 or Neotigason), a free acid and the main metabolite of etretinate (Ro 10-9359 or Tigason), is the most… Expand
Is this relevant?
1997
1997
Acitretin (Ro 10-1670, Neotigason), a second-generation monoaromatic retinoid, is the main acid derivative and active metabolite… Expand
Is this relevant?
1996
1996
Interferon-α combined with retinoid or PUVA is used for the treatment of cutaneous T-cell lymphoma. Anti-IFN-α antibodies (IFN ab… Expand
  • table 1
  • table 2
Is this relevant?
Review
1992
Review
1992
Acitretin was introduced as a replacement for etretinate, the ethyl ester of acitretin. Acitretin is eliminated at a much faster… Expand
  • figure 3
Is this relevant?
1989
1989
Developmental toxicity of the anti-psoriatic drug etretinate (Tegison) and some features of its metabolic conversion to etretin… Expand
Is this relevant?